1. Clinical Overview
A fixed-dose combination antiparkinsonian agent. Levodopa is a dopamine precursor that crosses the blood-brain barrier and is converted to dopamine in the brain, replenishing depleted dopamine levels in the basal ganglia. Carbidopa is a peripheral dopa decarboxylase inhibitor that prevents the peripheral conversion of levodopa to dopamine, allowing more levodopa to reach the brain and reducing peripheral side effects like nausea and vomiting. This combination is the cornerstone of symptomatic treatment for Parkinson's disease.
| Onset | Duration | Bioavailability |
|---|---|---|
| 30 to 60 minutes (oral) | Approximately 5 to 8 hours per dose, but varies with disease progression. | Levodopa: ~30% (highly variable due to extensive first-pass metabolism). Carbidopa bioavailability is not a primary clinical determinant. |
2. Mechanism of Action
Levodopa, the metabolic precursor of dopamine, crosses the blood-brain barrier via the large neutral amino acid (LNAA) transporter. In the nigrostriatal neurons, it is decarboxylated by aromatic L-amino acid decarboxylase (AADC) to form dopamine, replenishing the depleted striatal dopamine levels characteristic of Parkinson's disease. Carbidopa, which does not cross the BBB, inhibits peripheral AADC. This inhibition reduces the extracerebral conversion of levodopa to dopamine, minimizing peripheral side effects (nausea, cardiovascular) and allowing approximately 4-5 times more levodopa to reach the brain.
3. Indications & Uses
- Idiopathic Parkinson's Disease
- Post-encephalitic Parkinsonism
4. Dosage & Administration
Adult Dosage: Initial: 1 tablet (100mg/25mg) three times daily. Titrate gradually based on response and tolerance. Usual maintenance: 3 to 8 tablets per day in divided doses (typically 4-6 times daily). Doses > 8 tablets/day are rarely more effective.
Administration: Take on an empty stomach, 30-60 minutes before or 1-2 hours after meals, with a full glass of water to maximize absorption. If nausea occurs, may take with a small, low-protein snack (e.g., crackers). Do not crush or chew sustained-release formulations. Swallow whole.
5. Side Effects
Common side effects may include:
- Nausea
- Vomiting
- Anorexia
- Dizziness
- Orthostatic hypotension
- Dry mouth
- Dark discoloration of saliva, urine, or sweat (harmless)
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Non-selective MAO Inhibitors (e.g., Phenelzine, Tranylcypromine) | Risk of hypertensive crisis, hyperpyrexia. | Contraindicated |
| Antipsychotics (Typical: Haloperidol, Chlorpromazine; Atypical: Risperidone) | Antagonize dopaminergic effect, worsening parkinsonism. | Major |
| Antihypertensives | Additive hypotensive effect. | Moderate |
| Anticholinergics (e.g., Trihexyphenidyl) | May enhance efficacy but also side effects like confusion. | Moderate |
| Ferrous Sulfate (Iron) | Chelation reduces levodopa absorption and bioavailability. | Moderate |
| Protein-rich foods / Dietary supplements | Competes for absorption via LNAA transporter, reduces efficacy. | Moderate |
| Dopamine D2 receptor antagonists (Metoclopramide) | Worsens parkinsonian symptoms. | Major |
| Selective MAO-B Inhibitors (Selegiline, Rasagiline) | Enhanced dopaminergic effect; may increase dyskinesias. Dose adjustment may be needed. | Moderate |
7. Patient Counselling
- DO take medication exactly as prescribed, at regular intervals.
- DO take on an empty stomach (30-60 min before meals) unless nausea occurs.
- DO report any new skin lesions or moles to your doctor immediately.
- DO rise slowly from sitting/lying position to avoid dizziness.
- DON'T stop the medicine abruptly. Sudden withdrawal can cause Neuroleptic Malignant Syndrome (NMS).
- DON'T take with high-protein meals. Distribute protein intake evenly throughout the day.
- DON'T take iron supplements within 2-3 hours of your dose.
8. Toxicology & Storage
Overdose: Exaggeration of adverse effects: Severe nausea/vomiting, cardiac arrhythmias, hypotension, intense dyskinesias, confusion, agitation, hallucinations, psychosis. In severe cases: Coma.
Storage: Store below 30°C. Protect from light and moisture. Keep in the original blister pack or container. Keep out of reach of children.